Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial

1. Díez-Campelo, M.
2. López-Cadenas, F.
3. Xicoy, B.
4. Lumbreras, E.
5. González, T.
6. del Rey González, M.
7. Sánchez-García, J.
8. Coll Jordà, R.
9. Slama, B.
10. Hernández-Rivas, J.-Á.
11. Thepot, S.
12. Bernal, T.
13. Guerci-Bresler, A.
14. Bargay, J.
15. Amigo, M.L.
16. Preudhomme, C.
17. Fenwarth, L.
18. Platzbecker, U.
19. Götze, K.S.
20. Arar, A.
21. Toribio, S.
22. Del Cañizo, C.
23. Hernández-Rivas, J.M.
24. Fenaux, P.